A comparison of aspirin against rivaroxaban for venous thromboembolism prophylaxis after hip or knee arthroplasty: A meta-analysis.
Joshua XuAran KanagaratnamJacob Y CaoGurpreet S ChaggarWarwick BrucePublished in: Journal of orthopaedic surgery (Hong Kong) (2020)
Aspirin was not significantly different to rivaroxaban for prevention of VTE or adverse events after TKA or THA. However, this study was limited by the significant heterogeneity of the included studies. More large randomized studies are needed to add to this body of evidence.
Keyphrases
- venous thromboembolism
- direct oral anticoagulants
- low dose
- cardiovascular events
- case control
- antiplatelet therapy
- total knee arthroplasty
- single cell
- atrial fibrillation
- randomized controlled trial
- clinical trial
- total hip arthroplasty
- pulmonary embolism
- type diabetes
- placebo controlled
- phase iii
- cardiovascular disease
- phase ii
- study protocol